PKA activation enhances the long-term memory functhe cAMP/PKA pathway becomes disinhibited in the tions of posterior cortical and subcortical structures prefrontal cortex with advancing age. These data demsuch as the hippocampus. Based on this research in onstrate that PKA inhibition, rather than activation, is rodents, various pharmaceutical companies are develthe appropriate strategy for restoring prefrontal cortioping agents that enhance PKA activation as a treatcal cognitive abilities in the elderly. ment for age-related cognitive decline in humans (Langreth, 2002).
inhibited in the rat prefrontal cortex using Sp-cAMPS or Rp-cAMPS, respectively, similar to previous studies in young rats (Taylor et al., 1999) . Rats were tested on the delayed alternation task in a T-maze, a test of spatial working memory that is impaired by lesions to the prelimbic/infralimbic prefrontal cortex in rats (Divac, 1971) . A parallel study examined the effects of PKA activation in young versus aged monkeys performing a spatial working memory task, delayed response. As Sp-cAMPS and Rp-cAMPS do not penetrate the blood-brain barrier when given systemically, the monkeys were injected with the PDE4 inhibitor, rolipram, similar to previous research in rodents ( . Western blot analysis was performed on prefrontal cortex, hippocampus, and cerebellum of aged versus young adult rats to characterize age-related changes in the cAMP-PKA signaling pathway. Two AC isoforms were examined, AC2 and AC3. The regulatory and catalytic subunits of PKA and the phosphodiesterase isoforms PDE4a, PDE4b, and PDE4d were measured, as well as indirect measures of PKA activity, cAMP response element binding protein (CREB), and CRE binding. Activation of the cAMP/PKA pathway has been shown to upregulate CREB expression through CRE binding in a prefrontal cortex with advancing age and contributes to loss of prefrontal cortical cognitive function. cAMPS dose was selected based on previous work in young rats, which had shown that 21 nmol/0.5 l SpResults cAMPS significantly impaired performance, whereas 0.21 and 2.1 nmol/0.5 l had no effect (Taylor et al., Rats Young adult (9 months) and aged (approximately 24 1999). The Rp-cAMPS dose was based on a pilot study, in which young and aged rats were examined after a months when tested) rats were surgically implanted with guide cannula directed above the prefrontal cortex (Fig- wide range of Rp-cAMPS concentrations (0.021, 0.21, 2.1, 21, 42, and 84 nmol/0.5 l). In young rats, no dose ure 1). Animals were trained on a delayed alternation task in the T-maze, a test of spatial working memory that of Rp-cAMPS had any effect, with the exception that impairment was found at the highest dose (84 nmol: depends upon the functional integrity of the prefrontal cortex (Divac, 1971) . Delays began at "0" seconds (s) 51.9% Ϯ 7% correct, p ϭ 0.031 compared to vehicle). Seizures were observed in some animals following this and were gradually raised in 5 s intervals throughout the drug study as the animal performed Ն80% correct high dosage; thus, the relevance to cognitive function remains in question. No dose of Rp-cAMPS impaired on consecutive days (see Experimental Procedures). Thus, the number of sessions to achieve a delay of 15 the aged rats, including the 84 nmol dosage (62.5% Ϯ 7.3% correct, p ϭ 0.45 compared to vehicle). Pilot studs can be used to characterize the cognitive ability of the animal performing the task. Young adult rats (n ϭ 26) ies indicated that the 2.1 nmol/0.5 l Rp-cAMPS dose improved performance in aged rats; thus, this dose berequired an average of 26.7 Ϯ 3.7 testing sessions to achieve a 15 s delay, while aged rats (n ϭ 15) required came the focus of the current study (see below). Given the fragility of the aged animals and thus the limited an average of 49.9 Ϯ 8.4 testing sessions (p ϭ 0.004, unpaired t test). There was great variability in this meanumber of infusions that could be done in this age group, we focused on the 2.1 nmol/0.5 l dose for both Rpsure within the aged group, with some animals performing as well as the young, and others much impaired cAMPS and Sp-cAMPS in the current research. The effects of 2.1 nmol/0.5 l Sp-cAMPS and 2.1 nmol/ (see x axis in Figures 2A and 2B) .
Once the rats were performing in a stable manner 0.5 l Rp-cAMPS in aged rats depended upon the cognitive status of the animal (Figures 2A and 2B ). As shown (see Drug Infusions in Experimental Procedures), PKA signaling in the prefrontal cortex was manipulated prior in Figure 2A , the greater the number of test sessions needed to achieve a 15 s delay, the greater the impairto testing by infusing either the PKA activator Sp-cAMPS or the PKA inhibitor Rp-cAMPS into the prefrontal corment following infusion of Sp-cAMPS into the prefrontal cortex. In other words, the greater the cognitive deficit tex. Results were compared to vehicle infusion. The Sp-This effect was not simply an artifact of the delay length used in the task, as Rp-cAMPS did not improve the aged, cognitively intact rats even when it was administered when delay intervals were short. Correlational analyses showed no significant relationship between delay interval and response to either drug. Rather, the response to the drug depended on the overall prefrontal cortical abilities of the aged rat. In contrast to aged animals, there was no correlation between cognitive status and the response to 2.1 nmol Rp-cAMPS (r ϭ Ϫ0.065, ns) or 2.1 nmol/0.5l Sp-cAMPS (r ϭ 0.21, ns) in young adult rats. Interestingly, in aged rats there was a significant correlation between the degree of impairment induced by 2.1 nmol/0.5 l Sp-cAMPS and the amount of improvement seen when infusing 2.1 nmol/0.5 l RpcAMPS in the same aged animal (n ϭ 11, Pearson's test: r ϭ Ϫ0.76, p Ͻ 0.01, Figure 2C ). In other words, the more an aged rat was impaired by Sp-cAMPS, the more it was improved by Rp-cAMPS. These results contrast with studies in the hippocampus and posterior cortex, where Sp-cAMPS improves rather than impairs memory performance, providing more support for the idea that the prefrontal cortex is regulated differently than other brain regions.
Monkeys
Sp-cAMPS and Rp-cAMPS do not cross the blood-brain barrier, and thus cannot be administered systemically. However, the PDE4 inhibitor, rolipram, is capable of penetrating the brain following systemic administration and has been shown to enhance long-term memory consolidation in aged mice (Barad et al., 1998). Thus, roli- Rolipram had a significant effect on delayed response due to age, the more impaired the rat was during the testing session following an acute activation of PKA performance (significant within subjects effects of rolipram: F(4,48) ϭ 3.42, p ϭ 0.015], but its effects on perfor-(significant correlation between days to achieve 15 s delay and response to Sp-cAMPS: r ϭ Ϫ0.78; p Ͻ 0.01, mance were dependent upon the age of the animal [significant between subjects effects of age: F(1,12) ϭ 4.99, Pearson's test). Conversely, the greater the cognitive deficit due to age, the more the rats were improved by p ϭ 0.045]. As can be seen in Figure 3A , young monkeys tended to be improved by the 0.1 g/kg dose of rolipram PKA inhibition with Rp-cAMPS (r ϭ 0.70; p Ͻ 0.01, Figure  2B) 
Age-Related Changes in the PKA Pathway
In an effort to understand the underlying mechanisms involved in the differential response to PKA manipulations with age, young versus aged rat brains were compared using Western analyses and immunohistochemistry. Three regions of the brain associated with learning and memory were examined: the prefrontal cortex, hippocampus, and cerebellum. Basal PKA levels (regulatory or catalytic subunit immunoreactivity in all brain regions examined) were not affected by age (data not shown). Similarly, there were no age-related changes in PDE4a, PDE4b, or PDE4d (data not shown). Previous evidence had suggested that the AC system, which is upstream of PKA, may be more vulnerable to age, partic- shown in Figure 4A , CREB immunoreactivity tended to be increased (p ϭ 0.08) and CRE binding was significantly higher in the aged prefrontal cortex (p ϭ 0.006). In the hippocampus, AC3 immunoreactivity was sigpram compared to SEM ϭ 1.4% for saline). In contrast, aged animals showed no improvement with any dose of nificantly reduced in aged versus young rats (p ϭ 0.02; Table 1 ). As in the prefrontal cortex, there was no change rolipram, and performed significantly worse than saline performance following the 10.0 g/kg dose [ Figure 3B ; in AC2 (p ϭ 0.56; Table 1 ). However, unlike the prefrontal cortex, there was no change in CREB levels (p ϭ 0.74) F(1,6) ϭ 13.00, p ϭ 0.011]. There was no evidence of side effects at this dose (median sedation score of 0, or in the amount of CRE binding (p ϭ 0.26) ( Figure 4A ). Finally, in the cerebellum of aged rats, there was no normal behavior), suggesting that impairment arose from altered cognitive ability rather than from nonspechange found in the levels of AC isoforms (p Ͼ 0.7; Table  1 ). Similar to the hippocampus, there was no change in cific effects on performance. An analysis of 10.0 g/kg CREB levels (p ϭ 0.35) or in the amount of CRE binding CREB in the nucleus (Gonzalez and Montminy, 1989). As levels of phospho-CREB are a direct measure of PKA (p ϭ 0.9) ( Figure 4A ). Thus, none of the measures were different in the aged cerebellum.
activity, we examined the number of cells staining for phospho-CREB in aged versus young rats performing Overall, these results suggest that the prefrontal cortex may be affected differently than these other brain the delayed alternation task immediately prior to sacrifice. All but one of the aged rats showed impaired perforregions by the aging process, as evidenced by the in- tive deficits in the elderly. The present study may also explain why ␣ 2 adrenergic The disinhibition of PKA signaling in the aged prefrontal cortex may also be related to a history of stress agonists are so effective in enhancing prefrontal cortical cognitive function in aged animals. Studies in both roexposure. In young adult animals, acute exposure to uncontrollable stress rapidly impairs prefrontal cortical dents and monkeys have found that ␣ 2 adrenergic agonists improve prefrontal cortical but not nonprefrontal cognitive function, a mechanism that may have survival value under dangerous conditions (Arnsten, 1998). cortical cognitive functions and that these beneficial effects become increasingly prominent with advancing Stress-induced prefrontal cortex dysfunction results from high levels of catecholamine release in the prefronage (Arnsten and Goldman 
Subjects
Data Analysis Aged (20 months) and young (9 months) male, retired breeder
The relationship between efficacy of Sp-cAMPS or Rp-cAMPS in Sprague Dawley rats from Harlan (Indianapolis, IN) were singleaged rats versus cognitive status of the aged animals was assessed housed in filter frame cages. Aged rats were approximately 24 using a Pearson's r test. The factors were percent correct on the months old upon initiation of pharmacological testing. Animals were delayed alternation task following drug treatment, versus the numkept on a 12 hr light/dark cycle, and experiments were conducted ber of testing sessions required to achieve a 15 s delay. The relationduring the light phase. Rats were slowly habituated to a restricted ship between the efficacy of Sp-cAMPS versus Rp-cAMPS in the diet (16 gm/day per rat) of autoclaved Purina (St. Louis, MO) rat same aged rat was also assessed using a Pearson's r test. The chow during the first two weeks. Food was given immediately after factors were percent correct on the delayed alternation task followbehavioral testing and water was available ad libitum. Rats were ing Sp-cAMPS treatment versus the same animal's performance weighed weekly to confirm that they were not undergoing irregular under Rp-cAMPS during a different testing session. weight loss due to regulated diet. Food rewards during cognitive testing were highly palatable miniature chocolate chips. Rats were assigned a single experimenter who handled them extensively beMonkey Studies Subjects fore behavioral testing.
Delayed Alternation in T-Maze
The animals used in this study were rhesus monkeys (Macaca mulatta) ranging in age from 4 years (postpubescent) to over 30 years. Rats were habituated to a T-maze (dimensions, 90 ϫ 65 cm) until they were readily eating chocolate chips placed at the end of each Actual birthdates were not available for several of the aged animals who were wild caught. Ages were estimated by the veterinarians arm and were acclimated to handling. After habituation, rats were trained on the delayed alternation task. On the first trial, animals based on health records, teeth, and known history; several had been in the Yale colony for more than 15 years. The young adult monkeys were rewarded for entering either arm. Thereafter, for a total of 10 trials per session, rats were rewarded only if they entered the maze (4-18 years) consisted of 6 females and 1 male; the aged monkeys (18-30 ϩ years, n ϭ 7) were all female. The monkeys were individually arm that was not previously chosen. Between trials the choice point was wiped with alcohol to remove any olfactory clues. The delay housed and maintained on a diet of Purina monkey chow supplemented with fruit. Animals were always tested at the same time of between trials started at "0" s (i.e., about 1.5 s, minimum possible for delayed alternation) and was subsequently raised in 5 s intervals day immediately prior to feeding. Highly palatable food rewards (e.g., peanuts, raisins, or chocolate chips) were utilized during testas needed to maintain performance at 60% to 70% correct. Thus, delay achieved in a set number of testing sessions can be used as ing to minimize the need for dietary regulation. Delayed Response Testing an index of cognitive ability.
Cannulae Implantation
Cognitive testing occurred in a Wisconsin General Testing Apparatus (WGTA) situated in a sound-attenuating room. Background After training on the delayed alternation task, animals underwent stereotaxic implantation of chronic guide cannulae as described masking noise (60 dB, wideband) was also used to minimize auditory distractions. Each monkey was assigned to a single experimenter previously (Taylor et al., 1999). Guide cannulae (Plastics One; 2.8 mm) with stylettes were aimed dorsal to the medial prefrontal who knew the animal well but was unaware of the drug treatment conditions. The animals were tested twice a week with 3-4 days cortex (prelimbic prefrontal cortex; stereotaxic coordinates: anterioposterior, ϩ3.2 mm; mediolateral, Ϯ0.75 mm; dorsoventral, stylet separating each test session (e.g., Monday and Thursday). The monkeys had been previously trained on the spatial delayed response reaching to Ϫ4.2 mm) as shown in Figure 1 . Due to the rats' age and fragility, surgery was performed under low doses of a mixture task as described (Arnsten et al., 1988). During delayed response, the animal watched as the experimenter baited one of several foodof ketamine (80 mg/kg) and xylazine (10 mg/kg) injected (i.p.) prior to the start of the procedure. These agents were supplemented with wells with a food reward. The number of foodwells varied from two to four wells, depending on the monkey's performance level and gas anesthesia (isoflurane) administered during surgery via nosecone. Sterile stylets were inserted in the cannula to maintain patexperience with the task. Care was taken by the experimenter to ensure that the animal attended the baiting procedure. The foodency. Great care was taken to minimize pain and infection postoperatively to decrease stress to the animal. The region surrounding wells were then covered with identical cardboard plaques, and an opaque screen was lowered between the animal and the foodwells the cemented guide cannula was treated with triple antibiotic and cleaned daily if needed for a period of about a week. Animals were for a specified delay. At the end of the delay, the screen was raised and the animal was allowed to choose. Reward was quasi-randomly also acutely treated with Buprenex (0.01 mg/kg) to decrease pain.
Drug Infusions
distributed between the left and right wells over the 30 trials that made up a daily test session. Five different delay lengths (referred Rats were initially adapted to a mock infusion protocol to minimize any stress associated with the procedure. Rats were gently reto as delays A through E) were quasi-randomly distributed over these 30 trials. The shortest of these delays was less than 1 s (the strained while the stylets were removed and replaced with 30 gauge sterile infusion needles that extended to 4.5 mm dorsoventral below "0" s A delay). The remaining delays were in the range that for each individual monkey yielded baseline performance of about 70% the skull. Bilateral infusions were driven by a Harvard Apparatus (Hollinston, MA) syringe pump set at a flow rate of 0.25 l/min across all delays (i.e., 18-22 trials correct of the possible 30 trials). For example, the delays for one animal might be A ϭ 0, B ϭ 5, C ϭ using 25 l Hamilton syringes for an infusion time of 2 min. Needles remained inserted in place for 2 min after completion of the infusion. 10, D ϭ 15, and E ϭ 20 s. The "E" delay for the 7 young monkeys ranged between 20 and 80 s; for the aged monkeys it ranged from Stylets were inserted back into the cannulae, and behavioral testing was performed immediately after the infusion procedure. Drug treat-12 to 80 s. Please note that because the monkeys in this study have participated in research for varying amounts of time (some monkeys ments and vehicle were administered in a counterbalanced order with at least 1 week between each infusion. Counterbalancing enas long as 15 years, others for only three years), the "delay achieved" measure cannot be used as an accurate assessment of prefrontal sured that rats received drug infusions both early in the study when delays were short, as well as later in the study when delays were cortical function in monkeys as it can in rats, who were all tested for equal amounts of time. longer. Animals were required to exhibit stable baseline performance (2 consecutive test sessions of 60%-70% correct) prior to Sedation Assessment During each cognitive testing session, the experimenter rated the drug administration. Sp-cAMPS and Rp-cAMPS were purchased from Sigma RBI (St. Louis, MO). Sp-cAMPS and Rp-cAMPS were animal's level of sedation/agitation and aggression on rating scales.
Sedation and agitation were rated using a 9 point scale, where Ϫ4 ϭ of CRE binding were quantified by densitometry. The specificity of the CRE binding was determined by competition with different too agitated to test, Ϫ3 ϭ agitation that interferes with testing, Ϫ2 ϭ slight agitation that does not interfere with testing, Ϫ1 ϭ more alert concentrations (3 to 100 ng) of cold CRE, mutated CRE (GATCGGC TGACGTCTGAG), or human metalliothionein AP-1 oligonucleotides; than usual, 0 ϭ normal level of arousal, 1 ϭ quieter than usual, 2 ϭ sedated (drooping eyelids, slowed movements), 3 ϭ intermittent only unlabeled CRE oligonucleotide effectively competed with labeled CRE binding (not shown). For supershift analysis, 1 l of antisleeping, and 4 ϭ too sedated to test. Aggression was rated using a similar scale, where Ϫ3 ϭ dramatically more aggressive, Ϫ2 ϭ CREB antibody (Upstate) was incubated with cell extracts for 18 hr at 4ЊC before the addition of the labeled probe. The levels of CRE moderately more aggressive, Ϫ1 ϭ mildly more aggressive, 0 ϭ normal, 1 ϭ mildly less aggressive, 2 ϭ moderately less aggressive, binding were contrasted between young (9 months) and aged (24 months) rat tissue using unpaired t tests (two-tailed, significance and 3ϭ dramatically less aggressive. Drug Administration level ϭ 0.05). Phospho-CREB Immunohistochemistry Rolipram (purchased from Sigma RBI, St. Louis, MO) was dissolved in 0.2 ml 100% ethanol and 0.8 ml sterile saline and diluted with Young (9 months, n ϭ 4) and aged (24 months, n ϭ 4) Sprague Dawley rats were trained on the T-maze task until exhibiting stable saline to the appropriate concentration for the following doses: 0.01, 0.1, 1.0, 10.0, 50, or 100 g/kg. Drug solutions were made up fresh performance as described above. Each rat was tested on the delayed alternation task immediately before sacrifice. Their brains were each day under sterile conditions. Drug or vehicle was injected intramuscularly 1 hr prior to cognitive testing. The order of dose removed and placed in dry ice for subsequent storage at Ϫ80ЊC. Immunohistochemistry for phospho-CREB was performed using a administration was determined quasi-randomly, and the experimenter testing the animal was unaware of the treatment condition.
slide-based protocol. Cryocut sections (14 m thick) were briefly fixed in 4% paraformaldehyde followed by rinses in PBS. This was A washout period of at least 10 days occurred between drug treatments. Monkeys were required to return to stable baseline perforfollowed by a 5 min treatment with 1% hydrogen peroxide and two 5 min rinses in PBS. Sections were blocked to prevent nonspecific mance for 2 consecutive testing days prior to new drug treatment. Given these prolonged washout conditions, the research took apbinding of antibody by a 30 min treatment in a blocking solution containing 2.5% BSA. Sections were incubated overnight at 4ЊC in proximately 18 months to complete.
Data Analysis
antibody solution (0.25% Triton X-100, 1% BSA in PBS) containing anti-phospho-CREB antibody (Upstate Biotechnology) at 1:2000 diThe rolipram data from young versus aged monkeys were analyzed using a two-way analysis of variance (2-ANOVA-R) with a within lution. Antibody-treated sections were given three 5 min washes with PBS to remove unbound primary antibody and were incubated subjects factor of rolipram dosage and a between subjects factor of age. Planned comparison (test of effects) examined the effects in peroxidase-conjugated goat anti-rabbit IgG at 1:400 dilution for 1 hr at room temperature. Unbound secondary antibody was reof specific rolipram doses versus saline for the young or aged monkeys. A more detailed analysis of the effects of 10 g/kg rolipram moved by three 5 min rinses in PBS. Sections were then incubated in a preformed avidin and biotinylated horseradish peroxidase macat each delay interval was performed on the data from the aged monkeys (2-ANOVA-R; within subjects factors of rolipram and delay romolecular complex (ABC reagent; Vector Labs, Burlingame, CA) for 1 hr. After this incubation, sections were rinsed three times in interval). Correlations between estimated age of the monkey and the response to rolipram were performed using a nonparametric PBS and then stained with the 3,3Ј-diaminobenzidine staining kit (Vector Labs) according to manufacturer's directions. Slides were Spearman test, as actual birthdates were only known for a subset of animals. air dried, dehydrated in an alcohol series, and coverslipped with distyrene/plasticizer/xylene mountant. Images of each region were transferred to a computer program for counting. Cell counts focused Biochemistry of Rat Brain on the prelimbic region of the prefrontal cortex and the CA3 region Subjects of hippocampus. The number of cells staining positive for phosphoYoung adult (9 months, n ϭ 6) and aged (24 months, n ϭ 6) male, CREB was counted in a double-blind fashion by two separate experiretired breeder Sprague Dawley rats were purchased from Harlan menters, one unaware of the hypothesis in question. The cell counts (Indianapolis, IN) and single-housed in filter frame cages under stanbetween the two experimenters were in 93.5% agreement. Four dard laboratory conditions as described above. Aged animals were brain slices were counted for immunopositive cells in each of the sacrificed by decapitation at the age of 24 months for biochemiregions examined. The number of cells for each slice was then cal analysis. averaged and used for statistical analysis using unpaired t tests Immunoblotting of Adenylyl Cyclase Isoforms and CREB (two-tailed, significance level ϭ 0.05). Extracts of prefrontal cortex, hippocampus, or cerebellum from 9-or 24-month-old animals were prepared for immunoblot analysis as
